- Filed
- Mar 16, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 6, 2026 | 5.29M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 5.63M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 5.44M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$29.81M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$49.28M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $31.37M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $13.9M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $57.96M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $61.65M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $106.18M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $4.22M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $6.24M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $4.31M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $6.45M |
| Current Assets | FY 2025 · Dec 31, 2025 | $61.25M |
| Current Assets | FY 2025 · Dec 31, 2024 | $67.84M |
| Total Assets | FY 2025 · Dec 31, 2025 | $62.26M |
| Total Assets | FY 2025 · Dec 31, 2024 | $68.11M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$1.59 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$10.61 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$1.59 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$10.61 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $14.33M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $19.63M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $19.6M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $41.51M |
| Net Income | FY 2025 · Dec 31, 2025 | −$8.98M |
| Net Income | FY 2025 · Dec 31, 2024 | −$57.78M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$33.06M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$60.5M |
| Revenue | FY 2025 · Dec 31, 2025 | $858K |
| Revenue restated | FY 2025 · Dec 31, 2024 | $636K |